APPAN Life Science
Technologies
Index™
Life
Science Market
Analysis
(coming soon)
- Current P/E
- Furture P/E
- Cash balance
- Growth rates (with an
industry average)
- Profits per year
- Competitive Analysis
- Share price
- Estimatde Buyout Price per
Share (& total)
- Cash flow
- Available cash
- Growth Rate of Cash on Hand
- Market Size
- Revenue
- by Region
- by Customer Type
- Customer base
- Funding Sources
- NIH
Budgets
Keywords:
Biomarker, biomarkers, signature panel, epigenetics
Life
Science Equity Firms
- Thomas
Weisel Partners
- Leerink
Swann
- JP
Morgan
- Rodman
& Renshaw
- UBS
Global Life SCiences
- S.G. Cowen
- Barclays
Life
Science Industry Newsletters / Resources
|
Annual Revenues |
| Company |
2008 |
2007 |
2006 |
2005 |
2004 |
| Affymetrix |
|
|
|
$327.1
M |
$410.2
M |
| Agilent
Technologies |
|
|
|
|
|
| Beckman
Coulter |
|
|
|
|
|
| Becton,
Dickinson and
Company |
|
|
|
|
|
| Bio-Rad
Laboratories |
$1,784,244,000 |
$1,764,365,000 |
$1,461,052,000 |
|
|
| Caliper
Life Sciences |
$130,412,000 |
$134,054,000 |
$140,707,000 |
$107,871,000 |
$87,009,000 |
| Cepheid |
$170.627
M |
$169,627 M |
$129,473
M |
$87,352
M |
$85,010
M |
| Helicos
Bioscience |
|
|
|
|
|
| Illumina |
|
|
|
|
|
| Life
Technologies |
$3,280,344,000 |
$1,620,323,000 |
$1,281,747,000 |
$1,151,175,000 |
$1,079,137,000 |
| Millipore |
$1,654,410,000 |
$1,602,138,000 |
$1,531,555,000 |
$1,255,371,000 |
$991,031,000 |
| PerkinElmer |
|
|
|
|
|
| QIAGEN |
|
$892,975,000 |
$649,774,000 |
$465,778,000 |
$398,395,000 |
| Sequenom |
|
|
|
|
|
| Sigma-Aldrich |
|
|
|
|
|
| Thermo Fisher Scientific |
$10,109.7M |
$10,498.0M |
9,746.4M |
$3,791.6M |
$2,633.0M |
| WaferGen
Biosystems |
|
|
|
|
|
| Waters
Corporation |
|
|
|
|
Life
Science Technologies Index and LSTI are trademarks of
Appan Corporation.
Established September 16, 2009.